Sunny Pharmtech Inc. (TPEX:6676)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.40
+0.15 (1.05%)
Jun 27, 2025, 1:24 PM CST

Sunny Pharmtech Company Description

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally.

Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abortion and postpartum hemorrhage, as well as Cyclophosphamide injection for malignant diseases.

The company was founded in 2014 and is based in Taoyuan, Taiwan.

Sunny Pharmtech Inc.
Country Taiwan
Founded 2014
Industry Biotechnology
Sector Healthcare
Employees 154
CEO Yon-Lian Wu

Contact Details

Address:
No.255,Longyuan 1st Road
Taoyuan, 325002
Taiwan
Phone 886 3 480 9168
Website sunnypharmtech.com

Stock Details

Ticker Symbol 6676
Exchange Taipei Exchange
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0006676000
SIC Code 2834

Key Executives

Name Position
Yon-Lian Wu Chief Executive Officer
Kun-Hung Tsai Chief Financial Officer
Yung-Yi Chen Chief Operating Officer